All Antibody articles – Page 2

Business
Amgen partners to launch biosimilars in China

2017-09-29T12:07:00Z

US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
Business
AstraZeneca shares tumble after antibody failure

2017-07-28T13:55:00Z

Imfinzi and tremelimumab checkpoint inhibitor pairing fails to beat chemotherapy in lung cancer
Business
Celgene and BeiGene agree cancer partnership

2017-07-07T11:07:00Z

Immuno-oncology deal sees firms exchange licensing rights for antibody drugs
$C:\Users\traceys\Downloads$
Business
Seattle Genetics cancels Immunomedics deal

2017-05-19T10:41:00Z

Settlement also resolves disputes with shareholders
Business
Cholesterol drug withdrawn in patent dispute

2017-01-13T14:17:00Z

Ruling that Regeneron’s Praluent antibody infringes Amgen’s Repatha patent could stifle innovation
Business
Standard antibody will bolster biopharma

2016-08-04T00:00:00Z

New NIST reference material will help validate and compare analytical techniques
Business
AstraZeneca licenses skin drugs to Leo

2016-07-04T00:00:00Z

Offloading psoriasis and dermatitis antibodies continues AZ’s plan to refocus on fewer therapy areas
Business
Novartis partners with Xencor for cancer antibodies

2016-07-04T00:00:00Z

Deal deepens Novartis’s focus on immuno-oncology
Business
BioAtla and Pfizer to collaborate on antibody research

2015-12-21T00:00:00Z

Two-way agreement to share technology and royalties on new cancer drugs
Business
Pills, prices and politics

2015-12-17T00:00:00Z

2015 saw the pharmaceutical industry clash with lawmakers
Business
Amgen seeks injunction to protect patents

2014-10-23T00:00:00Z

Sanofi and Regeneron sued over cholesterol-regulating antibodies
News
Doctors turn to experimental Ebola treatments

2014-08-20T00:00:00Z

Drugs and vaccines untested in humans are being trialled on Ebola patients
Business
Merck & Co doubles up on Ablynx research deal

2014-02-04T00:00:00Z

Cancer nanobody R&D partnership could be worth €1.7 billion
Business
Sanofi suffers multiple sclerosis setback

2014-01-03T00:00:00Z

US drug agency will not approve alemtuzumab
Business
Celgene buys into anticancer antibodies

2013-12-04T00:00:00Z

Partners with OncoMed in a deal worth up to $3.3bn
Business
Roche backs biologics boom

2013-10-15T00:00:00Z

Swiss firm to invest heavily in manufacturing for complex biological drugs
Business
Nanobody inflammation drug attracts Abbvie

2013-09-25T00:00:00Z

$840m licensing deal shows support for antibody fragments
Business
First biosimilar antibody drugs approved in Europe

2013-09-11T00:00:00Z

European commission gives final approval to generic infliximab copies
Business
Biosimilar drugs step up complexity

2013-07-02T00:00:00Z

First generic monoclonal antibodies recommended for approval in Europe
News
Regeneron expands, creating 400 new jobs

2013-04-04T00:00:00Z

US biotech firm announces second expansion in six months